E
Elizabeth D. Reid
Researcher at Duke University
Publications - 3
Citations - 354
Elizabeth D. Reid is an academic researcher from Duke University. The author has contributed to research in topics: Case report form & Clinical trial. The author has an hindex of 3, co-authored 3 publications receiving 335 citations. Previous affiliations of Elizabeth D. Reid include Durham University.
Papers
More filters
Journal ArticleDOI
Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program
Jennifer S. Li,Eric L. Eisenstein,Henry G. Grabowski,Elizabeth D. Reid,Barry Mangum,Kevin A. Schulman,John V. Goldsmith,M. Dianne Murphy,Robert M. Califf,Daniel K. Benjamin +9 more
TL;DR: The economic return for pediatric exclusivity is variable and as an incentive to complete much-needed clinical trials in children, Pediatrics Exclusivity can generate lucrative returns or produce more modest returns on investment.
Journal ArticleDOI
Sensible approaches for reducing clinical trial costs.
Eric L. Eisenstein,Rory Collins,Beena S Cracknell,Oscar Podesta,Elizabeth D. Reid,Peter Sandercock,Yuriy Shakhov,Michael L. Terrin,Mary Ann Sellers,Robert M. Califf,Christopher B. Granger,Rafael Diaz +11 more
TL;DR: It is suggested that it is possible to reduce substantially the cost of large-scale clinical trials without compromising the scientific validity of their results and could free billions of dollars annually for additional clinical studies.
Journal ArticleDOI
The economic returns of pediatric clinical trials of antihypertensive drugs.
Carissa M. Baker-Smith,Daniel K. Benjamin,Daniel K. Benjamin,Henry G. Grabowski,Elizabeth D. Reid,Barry Mangum,John V. Goldsmith,M. Dianne Murphy,Rex Edwards,Eric L. Eisenstein,Jessica Sun,Robert M. Califf,Jennifer S. Li,Jennifer S. Li +13 more
TL;DR: It is found that, within a cohort of antihypertensive drugs, the Pediatric Exclusivity Provision has generated highly variable, yet lucrative returns to industry sponsors.